600329.SH
达仁堂
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 35.72
+1.05%Margins
Gross margin
75.2%
EBITDA margin
52.5%
EBIT margin
51.1%
Net margin
43.8%
FCF margin
8.4%
29.0%
Return on equity
20.9%
Return on assets
33.6%
Return on invested capital
0.45x
Asset turnover
CNY 527.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026